Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD
Trial ID or NCT#
Status
RECRUITING
Purpose
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy.
Official Title
Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for Asynchronous Texting Based Trauma Focused Therapy for PTSD
Eligibility Criteria
- - Over the age of 18 residing in the United States - Criterion A event measured by the Life Events Checklist for DSM-5 (LEC-5) - Significant symptoms of PTSD as evidenced by a score of 33 or above on the PCL-5 - PTSD symptoms that began or increased during the COVID pandemic (per self-report) - Registered/registering on Talkspace for messaging-based therapy - Ownership of a personal device for texting - Residence in a state with therapist capacity on the Talkspace platform
- - Acute risk for suicidal thoughts and/or behaviors measured by the Columbia Suicide Severity Rating Scale Lifetime-Recent Screen - Psychosis or substance abuse that requires prioritization of treatment and/or higher level of care
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Shannon Wiltsey Stirman, PhD
650-493-5000
View on ClinicalTrials.gov